Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $4,693 - $5,833
20 Added 0.45%
4,462 $1.28 Million
Q4 2021

May 04, 2022

BUY
$224.85 - $279.04 $998,783 - $1.24 Million
4,442 New
4,442 $1.23 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Offit Capital Advisors LLC Portfolio

Follow Offit Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Offit Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Offit Capital Advisors LLC with notifications on news.